Table 1 Demographic and baseline characteristics of the study patients
Cinacalcet dose before switching | 25 mg/day (n = 53) | 50 mg/day (n = 18) | ≥ 75 mg/day (n = 19) | Total (n = 90) | P value |
|---|---|---|---|---|---|
Female (%) | 16 (30.2) | 3 (16.7) | 8 (42.1) | 27 (30.0) | P = 0.227 |
Age (year) | 63.6 ± 8.7 | 61.6 ± 13.1 | 57.8 ± 10.8 | 62.0 ± 10.3 | P = 0.106 |
Dry weight (kg) | 59.2 ± 11.7 | 63.6 ± 17.4 | 58.7 ± 11.3 | 60.0 ± 12.9 | P = 0.414 |
Systolic blood pressure (mmHg) | 148.7 ± 25.0 | 144.8 ± 22.3 | 144.5 ± 18.0 | 147.0 ± 23.0 | P = 0.717 |
Duration of dialysis (years) | 15.1 ± 8.0 | 13.0 ± 6.7 | 16.5 ± 7.1 | 15.0 ± 7.6 | P = 0.356 |
spKt/V | 1.7 ± 0.3 | 1.6 ± 0.3 | 1.7 ± 0.2 | 1.7 ± 0.3 | P = 0.540 |
cCa (mg/dL) | 8.97 ± 0.40 | 9.07 ± 0.56 | 9.24 ± 0.41 | 9.05 ± 0.45 | P = 0.074 |
Phosphate (mg/dL) | 5.18 ± 1.09 | 5.64 ± 1.00 | 5.48 ± 1.34 | 5.34 ± 1.13 | P = 0.272 |
Intact PTH (pg/mL) | 180 ± 97 | 177 ± 123 | 289 ± 301 | 202 ± 170 | P = 0.040 |
Alb (g/dL) | 3.7 ± 0.3 | 3.8 ± 0.3 | 3.8 ± 0.3 | 3.8 ± 0.3 | P = 0.317 |
Mg (mg/dL) | 2.0 ± 0.3 | 2.6 ± 0.4 | 2.6 ± 0.3 | 2.5 ± 0.4 | P = 0.106 |